From Double-Strand Break Recognition to Cell-Cycle Checkpoint Activation: High Content and Resolution Image Cytometry Unmasks 53BP1 Multiple Roles in DNA Damage Response and p53 Action.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
05 Sep 2022
Historique:
received: 28 07 2022
revised: 25 08 2022
accepted: 02 09 2022
entrez: 9 9 2022
pubmed: 10 9 2022
medline: 14 9 2022
Statut: epublish

Résumé

53BP1 protein has been isolated in-vitro as a putative p53 interactor. From the discovery of its engagement in the DNA-Damage Response (DDR), its role in sustaining the activity of the p53-regulated transcriptional program has been frequently under-evaluated, even in the case of a specific response to numerous DNA Double-Strand Breaks (DSBs), i.e., exposure to ionizing radiation. The localization of 53BP1 protein constitutes a key to decipher the network of activities exerted in response to stress. We present here an automated-microscopy for image cytometry protocol to analyze the evolution of the DDR, and to demonstrate how 53BP1 moved from damaged sites, where the well-known interaction with the DSB marker γH2A.X takes place, to nucleoplasm, interacting with p53, and enhancing the transcriptional regulation of the guardian of the genome protein. Molecular interactions have been quantitatively described and spatiotemporally localized at the highest spatial resolution by a simultaneous analysis of the impairment of the cell-cycle progression. Thanks to the high statistical sampling of the presented protocol, we provide a detailed quantitative description of the molecular events following the DSBs formation. Single-Molecule Localization Microscopy (SMLM) Analysis finally confirmed the p53-53BP1 interaction on the tens of nanometers scale during the distinct phases of the response.

Identifiants

pubmed: 36077590
pii: ijms231710193
doi: 10.3390/ijms231710193
pmc: PMC9456172
pii:
doi:

Substances chimiques

Tumor Suppressor Protein p53 0
Tumor Suppressor p53-Binding Protein 1 0
DNA 9007-49-2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Nanomaterials (Basel). 2022 Feb 18;12(4):
pubmed: 35215014
J Cell Biol. 2006 Mar 13;172(6):823-34
pubmed: 16520385
Br J Cancer. 1999 Jan;79(2):267-77
pubmed: 9888468
Nat Rev Cancer. 2012 Dec;12(12):801-17
pubmed: 23175119
Front Cell Dev Biol. 2022 Jun 08;10:909696
pubmed: 35757003
Proc Natl Acad Sci U S A. 2014 Aug 5;111(31):11341-6
pubmed: 25049398
Bioconjug Chem. 2016 Jul 20;27(7):1690-6
pubmed: 27248443
Front Genet. 2021 Aug 02;12:723847
pubmed: 34408777
Angew Chem Int Ed Engl. 2015 Jul 6;54(28):8054-66
pubmed: 26088439
J Biol Chem. 1998 Oct 2;273(40):26061-8
pubmed: 9748285
Int J Mol Sci. 2022 Jun 24;23(13):
pubmed: 35806061
Curr Protoc Cytom. 2011 Apr;Chapter 9:Unit 9.36
pubmed: 21455970
Cancer Lett. 2015 Jan 1;356(1):58-71
pubmed: 24370566
Nat Methods. 2013 Apr;10(4):361-5
pubmed: 23503052
Curr Protoc Cytom. 2014 Oct 01;70:7.42.1-14
pubmed: 25271962
Int J Mol Sci. 2021 Oct 08;22(19):
pubmed: 34639222
Nat Methods. 2006 Dec;3(12):995-1000
pubmed: 17072308
J Biol Chem. 2003 Sep 19;278(38):36487-95
pubmed: 12824158
Mol Cell. 2016 Oct 6;64(1):51-64
pubmed: 27546791
Front Genet. 2022 Jan 31;13:793884
pubmed: 35173769
Front Oncol. 2020 Sep 04;10:1691
pubmed: 33014842
Semin Cancer Biol. 2016 Jun;37-38:51-64
pubmed: 27016036
Mol Cancer. 2019 Nov 26;18(1):169
pubmed: 31767017
Methods Mol Biol. 2017;1663:231-252
pubmed: 28924672
J Cell Biol. 2019 Aug 5;218(8):2444-2455
pubmed: 31324649
Cell Cycle. 2007 Aug 1;6(15):1831-6
pubmed: 17671427
Front Genet. 2021 Sep 30;12:738230
pubmed: 34659358
Nat Methods. 2008 Dec;5(12):1047-52
pubmed: 19029906
Curr Protoc Cytom. 2014 Oct 01;70:7.41.1-15
pubmed: 25271961
Nat Rev Mol Cell Biol. 2017 Nov;18(11):685-701
pubmed: 28875992
Proc Natl Acad Sci U S A. 2022 Mar 8;119(10):e2113233119
pubmed: 35235448
Mol Cell. 2021 Jun 17;81(12):2583-2595.e6
pubmed: 33961797
Nat Commun. 2017 May 12;8:15058
pubmed: 28497783
Nat Rev Mol Cell Biol. 2012 Sep;13(9):579-90
pubmed: 22914294
Cytometry A. 2013 Apr;83(4):333-43
pubmed: 23463605
Mol Cell. 2021 Jun 17;81(12):2596-2610.e7
pubmed: 33961796
Trends Cell Biol. 2014 Feb;24(2):108-17
pubmed: 24094932
Nat Genet. 2019 Jun;51(6):1011-1023
pubmed: 31110352
Cytometry A. 2013 Apr;83(4):344-55
pubmed: 23463591
Nat Cell Biol. 2012 Apr 08;14(5):502-9
pubmed: 22484486
Mutat Res Rev Mutat Res. 2021 Jul-Dec;788:108397
pubmed: 34893162
Genes Dev. 2020 Jan 1;34(1-2):7-23
pubmed: 31896689
Proc Natl Acad Sci U S A. 1994 Jun 21;91(13):6098-102
pubmed: 8016121

Auteurs

Laura Furia (L)

Department of Experimental Oncology, European Institute of Oncology IRCCS, 20139 Milan, Italy.

Simone Pelicci (S)

Department of Experimental Oncology, European Institute of Oncology IRCCS, 20139 Milan, Italy.

Mirco Scanarini (M)

Department of Experimental Oncology, European Institute of Oncology IRCCS, 20139 Milan, Italy.

Pier Giuseppe Pelicci (PG)

Department of Experimental Oncology, European Institute of Oncology IRCCS, 20139 Milan, Italy.
Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy.

Mario Faretta (M)

Department of Experimental Oncology, European Institute of Oncology IRCCS, 20139 Milan, Italy.

Articles similaires

DNA Methylation Humans DNA Animals Machine Learning
DNA Glycosylases Nucleosomes Humans 8-Hydroxy-2'-Deoxyguanosine DNA Repair
Humans Induced Pluripotent Stem Cells Schizophrenia Neural Stem Cells DNA Damage
Male STAT3 Transcription Factor Prostatic Neoplasms Animals Mice

Classifications MeSH